Medpace
MEDP
277 hedge funds and large institutions have $2.66B invested in Medpace in 2020 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 82 increasing their positions, 118 reducing their positions, and 31 closing their positions.
32% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 31
27% more capital invested
Capital invested by funds: $2.1B → $2.66B (+$561M)
3% more funds holding
Funds holding: 269 → 277 (+8)
1.56% more ownership
Funds ownership: 79.36% → 80.92% (+1.6%)
0% less call options, than puts
Call options by funds: $3.99M | Put options by funds: $4.01M
31% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 118
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$33.5M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$23M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$15.5M |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$11.6M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$6.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APG Asset Management
Amsterdam,
Netherlands
|
-$13.8M |
| 2 |
HAM
Hillcrest Asset Management
Plano,
Texas
|
-$11.8M |
| 3 |
Capital Fund Management (CFM)
Paris,
France
|
-$10.7M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$8.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.02M |
MEDP Hedge Fund Activity: Q2 2020 in Review
277 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2020, worth a combined $2.66B — up 27% from $2.1B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new MEDP positions and 31 closed out — a net gain of 10 holders — while 82 added to existing stakes and 118 trimmed.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $33.5M. The largest seller was APG Asset Management, cutting an estimated $13.8M.
- 277 institutional investors held Medpace (MEDP) as of Q2 2020, up from 269 in Q1 2020.
- Funds reported $2.66B of Medpace stock for Q2 2020, up 27% quarter-over-quarter.
- 41 funds opened new Medpace positions in Q2 2020 and 31 closed out, a net change of +10 holders.
- The largest Medpace buyer in Q2 2020 was Boston Trust Walden, an estimated $33.5M added.
- The largest Medpace seller in Q2 2020 was APG Asset Management, an estimated $13.8M sold.
Based on aggregated 13F filings for Q2 2020.